UCLA pioneers 'Delayed Tolerance' to free liver patients from lifelong toxic drugs
NCT ID NCT07269041
Summary
This study tests a new approach to help people who received a liver transplant from a living donor safely stop taking lifelong anti-rejection drugs. These drugs prevent organ rejection but have serious side effects. Researchers will use a short course of radiation and medication, followed by an infusion of the donor's stem cells, to try to 'retrain' the patient's immune system to accept the transplanted liver without needing daily drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UCLA Health 200 Medical Plaza
RECRUITINGLos Angeles, California, 90095, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.